RecruitingNot ApplicableNCT06836739

At-Home Genital Nerve Stimulation for SCI Bowel

At-Home Feasibility Trial of Genital Nerve Stimulation to Modulate Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury

Sponsor

MetroHealth Medical Center

Enrollment

12 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injury

Summary

The purpose of this study is to test whether electrical stimulation of the skin in the pelvic area (near the genitals) can reduce the reflexes that cause bowel accidents in people with spinal cord injuries. Current bowel treatments either involve diet and medications or surgery. This study will evaluate whether electrical stimulation can be an alternate option for bowel management. Researchers will: * Use an FDA approved Transcutaneous Electrical Nerve Stimulation (TENS) device off-label * Compare a target stimulation level to a placebo stimulation level Participants will: * Use electrical stimulation on the skin in the pelvic area for 6-8 hours each day for 4 weeks at home * Visit the research center 3 times to participate in exams and answer questions * Keep a daily diary of their bowel symptoms and stimulation times

Eligibility

Min Age: 18 Years

Inclusion Criteria7

Traumatic SCI.
Minimum of 6 months' post-injury.
Aged 18 years and older.
Neurological level of injury T12 or higher and AIS grade A-D, as defined by the ISNCSCI.
Score of 14 or higher on the ISCI BF BDS v2.1.
Response to genital nerve stimulation able to be elicited upon screening.
Able to understand and provide informed consent.

Exclusion Criteria4

Currently enrolled in another functional electrical stimulation (FES) research trial.
Females who are pregnant or planning to become pregnant in the duration of the trial (identified by self-report).
Presence of a cardiac pacemaker, implanted defibrillator, or other implanted functional electrical stimulation device if, upon clinical evaluation, it may have an interaction with GNS.
In the judgment of the PI and Co-Investigators, presence of medical complications that may interfere with the execution of the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGenital nerve stimulation

Genital nerve stimulation (GNS) will be administered via non-invasive surface skin electrodes. In men, two surface electrodes (1 cm diameter) will be placed on the dorsum of the penile shaft 2 cm apart. In women, one surface electrode will be placed near the clitoris and a second surface electrode will be placed on the labia majora or inner thigh. The electrodes will be connected to an electrical stimulator device.